Taipei Exchange - Delayed Quote TWD

NaviFUS Corp. (6872.TWO)

Compare
27.10
+0.20
+(0.74%)
As of 12:07:42 PM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,427.00
22,481.00
19,526.00
--
--
Cost of Revenue
15,404.00
10,654.00
3,033.00
--
--
Gross Profit
3,023.00
11,827.00
16,493.00
--
--
Operating Expense
119,487.00
88,253.00
89,392.00
82,581.00
64,910.00
Operating Income
-116,464.00
-76,426.00
-72,899.00
-82,581.00
-64,910.00
Net Non Operating Interest Income Expense
6,867.00
5,146.00
1,946.00
1,158.00
839.00
Pretax Income
-114,387.00
-69,565.00
-63,519.00
-82,660.00
-63,074.00
Net Income Common Stockholders
-110,285.00
-65,729.00
-63,593.00
-82,796.00
-61,639.00
Diluted NI Available to Com Stockholders
-110,285.00
-65,729.00
-63,593.00
-82,796.00
-61,639.00
Basic EPS
-1.85
-1.16
-1.12
-1.78
-1.80
Diluted EPS
-1.85
-1.16
-1.12
-1.78
-1.80
Basic Average Shares
60,204.57
56,991.49
56,991.49
46,512.59
34,221.99
Diluted Average Shares
60,204.57
56,991.49
56,991.49
46,512.59
34,221.99
Total Expenses
134,891.00
98,907.00
92,425.00
82,581.00
64,910.00
Net Income from Continuing & Discontinued Operation
-110,285.00
-65,729.00
-63,593.00
-82,796.00
-61,639.00
Normalized Income
-110,285.00
-65,729.00
-60,397.00
-82,796.00
-61,639.00
Interest Income
7,463.00
5,575.00
1,958.00
1,185.00
860.00
Interest Expense
596.00
429.00
12.00
27.00
21.00
Net Interest Income
6,867.00
5,146.00
1,946.00
1,158.00
839.00
EBIT
-113,791.00
-69,136.00
-63,507.00
-82,633.00
-63,053.00
EBITDA
-95,252.00
-55,795.00
-53,840.00
-73,141.00
-52,909.00
Reconciled Cost of Revenue
15,404.00
10,654.00
3,033.00
--
--
Reconciled Depreciation
18,539.00
13,341.00
9,667.00
9,492.00
10,144.00
Net Income from Continuing Operation Net Minority Interest
-110,285.00
-65,729.00
-63,593.00
-82,796.00
-61,639.00
Total Unusual Items Excluding Goodwill
--
--
-3,196.00
--
--
Total Unusual Items
--
--
-3,196.00
--
--
Normalized EBITDA
-95,252.00
-55,795.00
-50,644.00
-73,141.00
-52,909.00
12/31/2020 - 6/23/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6876.TWO LAUNXP Biomedical Co., Ltd
18.60
-0.27%
 
6999.TWO Han Biomedical
36.00
+3.75%
 
7729.TWO SBI
20.30
-4.02%
 
4197.TWO Visgeneer Inc.
9.78
0.00%
 
7754.TWO AnnJi
32.70
-3.25%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.49
-4.07%
 
6879.TWO TCI GENE Inc.
52.00
0.00%
 
7776.TWO Anya
38.60
+7.67%
 
6976.TWO Acepodia, Inc.
17.70
-1.39%
 
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%